nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromazepam—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.27	1	CbGbCtD
Bromazepam—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.0178	0.0714	CcSEcCtD
Bromazepam—GABRR3—peripheral nervous system—amyotrophic lateral sclerosis	0.0165	0.0634	CbGeAlD
Bromazepam—Hostility—Riluzole—amyotrophic lateral sclerosis	0.016	0.0642	CcSEcCtD
Bromazepam—GABRR2—peripheral nervous system—amyotrophic lateral sclerosis	0.0143	0.055	CbGeAlD
Bromazepam—GABRR1—peripheral nervous system—amyotrophic lateral sclerosis	0.0138	0.0529	CbGeAlD
Bromazepam—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.0129	0.0516	CcSEcCtD
Bromazepam—GABRQ—nerve—amyotrophic lateral sclerosis	0.0129	0.0494	CbGeAlD
Bromazepam—GABRR3—nerve—amyotrophic lateral sclerosis	0.0129	0.0494	CbGeAlD
Bromazepam—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0502	CcSEcCtD
Bromazepam—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0472	CcSEcCtD
Bromazepam—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0472	CcSEcCtD
Bromazepam—GABRR2—nerve—amyotrophic lateral sclerosis	0.0111	0.0428	CbGeAlD
Bromazepam—GABRR1—nerve—amyotrophic lateral sclerosis	0.0107	0.0412	CbGeAlD
Bromazepam—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00855	0.0343	CcSEcCtD
Bromazepam—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00761	0.0305	CcSEcCtD
Bromazepam—GABRA6—hindbrain—amyotrophic lateral sclerosis	0.00668	0.0257	CbGeAlD
Bromazepam—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00659	0.0264	CcSEcCtD
Bromazepam—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00643	0.0258	CcSEcCtD
Bromazepam—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00628	0.0252	CcSEcCtD
Bromazepam—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00611	0.0245	CcSEcCtD
Bromazepam—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00604	0.0242	CcSEcCtD
Bromazepam—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00567	0.0227	CcSEcCtD
Bromazepam—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.00492	0.0189	CbGeAlD
Bromazepam—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.00449	0.0173	CbGeAlD
Bromazepam—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00442	0.0177	CcSEcCtD
Bromazepam—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00437	0.0175	CcSEcCtD
Bromazepam—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.00434	0.0167	CbGeAlD
Bromazepam—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00416	0.0167	CcSEcCtD
Bromazepam—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00413	0.0166	CcSEcCtD
Bromazepam—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.0039	0.0156	CcSEcCtD
Bromazepam—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00387	0.0155	CcSEcCtD
Bromazepam—GABRA6—brainstem—amyotrophic lateral sclerosis	0.00383	0.0147	CbGeAlD
Bromazepam—Tension—Riluzole—amyotrophic lateral sclerosis	0.0038	0.0152	CcSEcCtD
Bromazepam—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00376	0.0151	CcSEcCtD
Bromazepam—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00372	0.0149	CcSEcCtD
Bromazepam—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00363	0.0145	CcSEcCtD
Bromazepam—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00356	0.0143	CcSEcCtD
Bromazepam—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00342	0.0137	CcSEcCtD
Bromazepam—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00335	0.0135	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00327	0.0131	CcSEcCtD
Bromazepam—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00322	0.0129	CcSEcCtD
Bromazepam—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00319	0.0128	CcSEcCtD
Bromazepam—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00316	0.0127	CcSEcCtD
Bromazepam—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.0031	0.0124	CcSEcCtD
Bromazepam—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00308	0.0124	CcSEcCtD
Bromazepam—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00307	0.0123	CcSEcCtD
Bromazepam—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00301	0.0121	CcSEcCtD
Bromazepam—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00295	0.0118	CcSEcCtD
Bromazepam—GABRR3—nervous system—amyotrophic lateral sclerosis	0.00289	0.0111	CbGeAlD
Bromazepam—GABRQ—nervous system—amyotrophic lateral sclerosis	0.00289	0.0111	CbGeAlD
Bromazepam—GABRB2—brainstem—amyotrophic lateral sclerosis	0.00282	0.0108	CbGeAlD
Bromazepam—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00281	0.0113	CcSEcCtD
Bromazepam—GABRD—medulla oblongata—amyotrophic lateral sclerosis	0.00279	0.0107	CbGeAlD
Bromazepam—GABRQ—central nervous system—amyotrophic lateral sclerosis	0.00278	0.0107	CbGeAlD
Bromazepam—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00278	0.0112	CcSEcCtD
Bromazepam—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00275	0.011	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00273	0.0109	CcSEcCtD
Bromazepam—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00272	0.0109	CcSEcCtD
Bromazepam—GABRG1—medulla oblongata—amyotrophic lateral sclerosis	0.00269	0.0103	CbGeAlD
Bromazepam—GABRB1—medulla oblongata—amyotrophic lateral sclerosis	0.0026	0.01	CbGeAlD
Bromazepam—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.0026	0.0104	CcSEcCtD
Bromazepam—GABRA2—brainstem—amyotrophic lateral sclerosis	0.00258	0.0099	CbGeAlD
Bromazepam—GABRG3—nervous system—amyotrophic lateral sclerosis	0.00253	0.00973	CbGeAlD
Bromazepam—GABRR2—nervous system—amyotrophic lateral sclerosis	0.00251	0.00964	CbGeAlD
Bromazepam—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00249	0.00957	CbGeAlD
Bromazepam—GABRG3—central nervous system—amyotrophic lateral sclerosis	0.00244	0.00937	CbGeAlD
Bromazepam—GABRR1—nervous system—amyotrophic lateral sclerosis	0.00241	0.00928	CbGeAlD
Bromazepam—GABRG1—spinal cord—amyotrophic lateral sclerosis	0.00239	0.00921	CbGeAlD
Bromazepam—GABRR2—cerebellum—amyotrophic lateral sclerosis	0.00236	0.00907	CbGeAlD
Bromazepam—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00934	CcSEcCtD
Bromazepam—GABRR1—central nervous system—amyotrophic lateral sclerosis	0.00232	0.00893	CbGeAlD
Bromazepam—GABRB1—spinal cord—amyotrophic lateral sclerosis	0.00232	0.00893	CbGeAlD
Bromazepam—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00909	CcSEcCtD
Bromazepam—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00897	CcSEcCtD
Bromazepam—GABRQ—brain—amyotrophic lateral sclerosis	0.00221	0.00849	CbGeAlD
Bromazepam—GABRD—nervous system—amyotrophic lateral sclerosis	0.0021	0.00806	CbGeAlD
Bromazepam—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00209	0.00838	CcSEcCtD
Bromazepam—GABRD—central nervous system—amyotrophic lateral sclerosis	0.00202	0.00776	CbGeAlD
Bromazepam—GABRG1—nervous system—amyotrophic lateral sclerosis	0.00202	0.00776	CbGeAlD
Bromazepam—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00806	CcSEcCtD
Bromazepam—GABRA6—nervous system—amyotrophic lateral sclerosis	0.00201	0.00771	CbGeAlD
Bromazepam—Rash—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00799	CcSEcCtD
Bromazepam—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00798	CcSEcCtD
Bromazepam—Headache—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00794	CcSEcCtD
Bromazepam—GABRD—cerebellum—amyotrophic lateral sclerosis	0.00197	0.00758	CbGeAlD
Bromazepam—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.00197	0.00756	CbGeAlD
Bromazepam—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.00197	0.00756	CbGeAlD
Bromazepam—GABRB1—nervous system—amyotrophic lateral sclerosis	0.00196	0.00752	CbGeAlD
Bromazepam—GABRA5—nervous system—amyotrophic lateral sclerosis	0.00195	0.00748	CbGeAlD
Bromazepam—GABRG1—central nervous system—amyotrophic lateral sclerosis	0.00194	0.00747	CbGeAlD
Bromazepam—GABRG3—brain—amyotrophic lateral sclerosis	0.00193	0.00744	CbGeAlD
Bromazepam—GABRA6—central nervous system—amyotrophic lateral sclerosis	0.00193	0.00743	CbGeAlD
Bromazepam—GABRG1—cerebellum—amyotrophic lateral sclerosis	0.0019	0.0073	CbGeAlD
Bromazepam—GABRA6—cerebellum—amyotrophic lateral sclerosis	0.00189	0.00726	CbGeAlD
Bromazepam—GABRB1—central nervous system—amyotrophic lateral sclerosis	0.00188	0.00724	CbGeAlD
Bromazepam—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00188	0.00753	CcSEcCtD
Bromazepam—GABRA5—central nervous system—amyotrophic lateral sclerosis	0.00187	0.0072	CbGeAlD
Bromazepam—GABRR1—brain—amyotrophic lateral sclerosis	0.00184	0.00709	CbGeAlD
Bromazepam—GABRB1—cerebellum—amyotrophic lateral sclerosis	0.00184	0.00708	CbGeAlD
Bromazepam—GABRA3—nervous system—amyotrophic lateral sclerosis	0.00181	0.00697	CbGeAlD
Bromazepam—GABRA4—nervous system—amyotrophic lateral sclerosis	0.00177	0.00679	CbGeAlD
Bromazepam—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.00175	0.00674	CbGeAlD
Bromazepam—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.00175	0.00674	CbGeAlD
Bromazepam—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.00174	0.00671	CbGeAlD
Bromazepam—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.00174	0.00667	CbGeAlD
Bromazepam—GABRA4—central nervous system—amyotrophic lateral sclerosis	0.0017	0.00654	CbGeAlD
Bromazepam—GABRA4—cerebellum—amyotrophic lateral sclerosis	0.00166	0.00639	CbGeAlD
Bromazepam—GABRD—brain—amyotrophic lateral sclerosis	0.0016	0.00616	CbGeAlD
Bromazepam—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00155	0.00595	CbGeAlD
Bromazepam—GABRG1—brain—amyotrophic lateral sclerosis	0.00154	0.00593	CbGeAlD
Bromazepam—GABRA6—brain—amyotrophic lateral sclerosis	0.00153	0.0059	CbGeAlD
Bromazepam—GABRB3—medulla oblongata—amyotrophic lateral sclerosis	0.00151	0.0058	CbGeAlD
Bromazepam—GABRB1—brain—amyotrophic lateral sclerosis	0.0015	0.00575	CbGeAlD
Bromazepam—GABRA5—brain—amyotrophic lateral sclerosis	0.00149	0.00572	CbGeAlD
Bromazepam—GABRG2—nervous system—amyotrophic lateral sclerosis	0.00148	0.00568	CbGeAlD
Bromazepam—GABRB2—nervous system—amyotrophic lateral sclerosis	0.00148	0.00568	CbGeAlD
Bromazepam—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.00142	0.00547	CbGeAlD
Bromazepam—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.00142	0.00547	CbGeAlD
Bromazepam—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.00139	0.00534	CbGeAlD
Bromazepam—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.00139	0.00534	CbGeAlD
Bromazepam—GABRA3—brain—amyotrophic lateral sclerosis	0.00138	0.00532	CbGeAlD
Bromazepam—GABRA4—brain—amyotrophic lateral sclerosis	0.00135	0.00519	CbGeAlD
Bromazepam—GABRA2—nervous system—amyotrophic lateral sclerosis	0.00135	0.00519	CbGeAlD
Bromazepam—GABRB3—spinal cord—amyotrophic lateral sclerosis	0.00135	0.00518	CbGeAlD
Bromazepam—GABRE—nervous system—amyotrophic lateral sclerosis	0.00134	0.00514	CbGeAlD
Bromazepam—GABRA1—nervous system—amyotrophic lateral sclerosis	0.0013	0.00501	CbGeAlD
Bromazepam—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.0013	0.005	CbGeAlD
Bromazepam—GABRE—central nervous system—amyotrophic lateral sclerosis	0.00129	0.00495	CbGeAlD
Bromazepam—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.00127	0.00488	CbGeAlD
Bromazepam—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.00126	0.00483	CbGeAlD
Bromazepam—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.00123	0.00472	CbGeAlD
Bromazepam—GABRB3—nervous system—amyotrophic lateral sclerosis	0.00113	0.00436	CbGeAlD
Bromazepam—GABRG2—brain—amyotrophic lateral sclerosis	0.00113	0.00434	CbGeAlD
Bromazepam—GABRB2—brain—amyotrophic lateral sclerosis	0.00113	0.00434	CbGeAlD
Bromazepam—GABRB3—central nervous system—amyotrophic lateral sclerosis	0.00109	0.0042	CbGeAlD
Bromazepam—GABRB3—cerebellum—amyotrophic lateral sclerosis	0.00107	0.0041	CbGeAlD
Bromazepam—GABRA2—brain—amyotrophic lateral sclerosis	0.00103	0.00397	CbGeAlD
Bromazepam—GABRE—brain—amyotrophic lateral sclerosis	0.00102	0.00393	CbGeAlD
Bromazepam—GABRA1—brain—amyotrophic lateral sclerosis	0.000997	0.00383	CbGeAlD
Bromazepam—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.00096	0.00369	CbGeAlD
Bromazepam—GABRB3—brain—amyotrophic lateral sclerosis	0.000867	0.00333	CbGeAlD
Bromazepam—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000856	0.00329	CbGeAlD
Bromazepam—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000722	0.00277	CbGeAlD
Bromazepam—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000695	0.00267	CbGeAlD
Bromazepam—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000679	0.00261	CbGeAlD
Bromazepam—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000581	0.00223	CbGeAlD
Bromazepam—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000559	0.00215	CbGeAlD
Bromazepam—CYP2E1—brain—amyotrophic lateral sclerosis	0.000552	0.00212	CbGeAlD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00047	0.00213	CbGpPWpGaD
Bromazepam—GABRA4—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00047	0.00212	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000469	0.00212	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000468	0.00212	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000468	0.00212	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000465	0.0021	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000465	0.0021	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00046	0.00208	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00046	0.00208	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000457	0.00207	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000454	0.00205	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000453	0.00205	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000452	0.00204	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000452	0.00204	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00045	0.00203	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000449	0.00203	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000449	0.00203	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000446	0.00202	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000441	0.00199	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000441	0.00199	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00044	0.00199	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000439	0.00198	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000439	0.00198	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000437	0.00198	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000434	0.00196	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000434	0.00196	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000432	0.00195	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000432	0.00195	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00043	0.00195	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000429	0.00194	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000429	0.00194	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000424	0.00192	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000422	0.00191	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000421	0.00191	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000419	0.00189	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000417	0.00189	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000414	0.00187	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000414	0.00187	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000411	0.00186	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00041	0.00185	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000409	0.00185	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000409	0.00185	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000407	0.00184	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000404	0.00183	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000404	0.00183	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000404	0.00183	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000403	0.00182	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000401	0.00181	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000401	0.00181	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.0004	0.00181	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000397	0.0018	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000397	0.0018	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000396	0.00179	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000393	0.00178	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000391	0.00177	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000389	0.00176	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000386	0.00174	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000385	0.00174	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000385	0.00174	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000385	0.00174	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000379	0.00171	CbGpPWpGaD
Bromazepam—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000377	0.00171	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000372	0.00168	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00037	0.00167	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000369	0.00167	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000369	0.00167	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000364	0.00165	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000363	0.00164	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000362	0.00164	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00036	0.00163	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000359	0.00163	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000359	0.00162	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000359	0.00162	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000353	0.0016	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000352	0.00159	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000352	0.00159	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000352	0.00159	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000348	0.00157	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000347	0.00157	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000346	0.00157	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000346	0.00157	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000346	0.00156	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000344	0.00156	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000344	0.00156	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000343	0.00155	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00034	0.00154	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000338	0.00153	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000338	0.00153	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000337	0.00153	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000337	0.00152	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000337	0.00152	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000331	0.0015	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000329	0.00149	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00032	0.00145	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000317	0.00144	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000314	0.00142	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000308	0.0014	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000306	0.00139	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000302	0.00137	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000301	0.00136	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.0003	0.00136	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.0003	0.00136	CbGpPWpGaD
Bromazepam—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000296	0.00134	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000295	0.00133	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000295	0.00133	CbGpPWpGaD
Bromazepam—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000294	0.00133	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00029	0.00131	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000286	0.0013	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000286	0.0013	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000286	0.0013	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000286	0.0013	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000277	0.00125	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000273	0.00124	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000268	0.00121	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000268	0.00121	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000263	0.00119	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000259	0.00117	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000255	0.00115	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000255	0.00115	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000255	0.00115	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000243	0.0011	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000236	0.00107	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000236	0.00107	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000233	0.00106	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000232	0.00105	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000232	0.00105	CbGpPWpGaD
Bromazepam—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000231	0.00104	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000227	0.00103	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000223	0.00101	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00022	0.000994	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00022	0.000994	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000219	0.00099	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000217	0.000983	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000217	0.000982	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000217	0.000982	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000214	0.000966	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00021	0.000951	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000209	0.000945	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000207	0.000936	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000207	0.000934	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000198	0.000898	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000198	0.000898	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000196	0.000886	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000193	0.000875	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000193	0.000872	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000193	0.000872	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000189	0.000856	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000189	0.000856	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000189	0.000854	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000187	0.000844	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000186	0.000842	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000186	0.000842	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000185	0.000836	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000185	0.000836	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000182	0.000821	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000182	0.000821	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000177	0.0008	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000176	0.000794	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000172	0.000777	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000169	0.000763	CbGpPWpGaD
Bromazepam—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000167	0.000756	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000166	0.00075	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000165	0.000747	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000165	0.000745	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000162	0.000732	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000161	0.00073	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000161	0.000728	CbGpPWpGaD
Bromazepam—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.00016	0.000723	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000159	0.000718	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000159	0.000718	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000156	0.000704	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000153	0.000694	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000151	0.000682	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000147	0.000666	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000141	0.00064	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000139	0.000629	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000137	0.000619	CbGpPWpGaD
Bromazepam—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.00013	0.000589	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000129	0.000582	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000121	0.000549	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00012	0.000543	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000119	0.000539	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000119	0.000539	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000118	0.000535	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000113	0.000512	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.00011	0.000496	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000109	0.000493	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000103	0.000466	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000101	0.000458	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	9.53e-05	0.000431	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.35e-05	0.000423	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.22e-05	0.000417	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	9.2e-05	0.000416	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	9.2e-05	0.000416	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	8.82e-05	0.000399	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	8.62e-05	0.00039	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	8.58e-05	0.000388	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	8.41e-05	0.00038	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.82e-05	0.000354	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	7.35e-05	0.000333	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.22e-05	0.000326	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	7.17e-05	0.000324	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	7.17e-05	0.000324	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.12e-05	0.000322	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6.68e-05	0.000302	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	6.65e-05	0.000301	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	6.55e-05	0.000296	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	6.53e-05	0.000295	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.09e-05	0.000276	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	6.03e-05	0.000273	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	5.73e-05	0.000259	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	5.53e-05	0.00025	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	5.53e-05	0.00025	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	5.18e-05	0.000234	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	5.06e-05	0.000229	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	5.04e-05	0.000228	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	4.95e-05	0.000224	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.7e-05	0.000213	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	4.65e-05	0.00021	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	4.42e-05	0.0002	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.24e-05	0.000192	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	4e-05	0.000181	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	3.93e-05	0.000178	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	3.82e-05	0.000173	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	3.62e-05	0.000164	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.48e-05	0.000158	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.3e-05	0.000149	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.03e-05	0.000137	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.98e-05	0.000135	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.8e-05	0.000127	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.72e-05	0.000123	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.66e-05	0.00012	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.44e-05	0.000111	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.39e-05	0.000108	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.3e-05	0.000104	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.05e-05	9.28e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	2.01e-05	9.1e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.89e-05	8.53e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.86e-05	8.42e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.6e-05	7.23e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	1.55e-05	7.02e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.47e-05	6.65e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.38e-05	6.23e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.23e-05	5.58e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.21e-05	5.47e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.13e-05	5.13e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.06e-05	4.81e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	9.33e-06	4.22e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.29e-06	3.75e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.39e-06	2.89e-05	CbGpPWpGaD
